Procept BioRobotics Corp (NASDAQ: PRCT) on Monday, soared 5.07% from the previous trading day, before settling in for the closing price of $84.30. Within the past 52 weeks, PRCT’s price has moved between $39.48 and $103.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 142.74% over the last five years. The company achieved an average annual earnings per share of 22.27%. With a float of $51.55 million, this company’s outstanding shares have now reached $52.15 million.
The firm has a total of 626 workers. Let’s measure their productivity. In terms of profitability, gross margin is 56.09%, operating margin of -53.27%, and the pretax margin is -50.07%.
Procept BioRobotics Corp (PRCT) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Procept BioRobotics Corp is 5.23%, while institutional ownership is 84.19%. The most recent insider transaction that took place on Dec 04 ’24, was worth 2,568,844. In this transaction President, CEO of this company sold 26,423 shares at a rate of $97.22, taking the stock ownership to the 152,762 shares. Before that another transaction happened on Dec 04 ’24, when Company’s EVP, CLO, CORP. SEC. sold 28,092 for $97.13, making the entire transaction worth $2,728,574. This insider now owns 52,472 shares in total.
Procept BioRobotics Corp (PRCT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.50% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Procept BioRobotics Corp (PRCT) is currently performing well based on its current performance indicators. A quick ratio of 5.07 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Analysing the last 5-days average volume posted by the [Procept BioRobotics Corp, PRCT], we can find that recorded value of 0.5 million was lower than the volume posted last year of 0.57 million. As of the previous 9 days, the stock’s Stochastic %D was 77.47%. Additionally, its Average True Range was 3.70.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 62.74%, which indicates a significant decrease from 68.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.97% in the past 14 days, which was lower than the 73.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $90.08, while its 200-day Moving Average is $71.53. Now, the first resistance to watch is $90.39. This is followed by the second major resistance level at $92.22. The third major resistance level sits at $94.95. If the price goes on to break the first support level at $85.84, it is likely to go to the next support level at $83.11. Now, if the price goes above the second support level, the third support stands at $81.28.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
Market capitalization of the company is 4.82 billion based on 52,183K outstanding shares. Right now, sales total 136,190 K and income totals -105,900 K. The company made 58,370 K in profit during its latest quarter, and -20,970 K in sales during its previous quarter.
